share_log

B of A Securities Downgrades ProKidney to Neutral, Lowers Price Target to $2

B of A Securities Downgrades ProKidney to Neutral, Lowers Price Target to $2

Bof A证券将ProKidney的评级下调至中性,将目标股价下调至2美元
Benzinga ·  01/02 09:08

B of A Securities analyst Jason Gerberry downgrades ProKidney (NASDAQ:PROK) from Buy to Neutral and lowers the price target from $8 to $2.

B of A Securities分析师杰森·格伯里将ProKidney(纳斯达克股票代码:PROK)的评级从买入下调至中性,并将目标股价从8美元下调至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发